Literature DB >> 12077715

Dyslipidemia and the vulnerable plaque.

John A Farmer1, Antonio M Gotto.   

Abstract

In the last decade, an increasingly sophisticated understanding of the pathogenesis of atherosclerosis and its cardiovascular consequences has emerged. The characteristics of the unstable atherosclerotic plaque, the substrate for the majority of acute coronary events, have been well defined: mild-to-moderate stenosis, a lipid-rich pool, few smooth muscle cells, a friable fibrous cap, and macrophage infiltration. Lipid modification, an important cardiovascular risk reduction strategy, induces a number of effects at the vascular level that may contribute to the clinical benefits seen in large-scale, prospective prevention trials. New developments in imaging technologies may afford improved opportunities to visualize the at-risk plaque and may provide new insights into the optimal management of the unstable plaque. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12077715     DOI: 10.1053/pcad.2002.123474

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  8 in total

Review 1.  Regression of atherosclerosis: insights from animal and clinical studies.

Authors:  Jonathan E Feig
Journal:  Ann Glob Health       Date:  2013-12-25       Impact factor: 2.462

Review 2.  The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.

Authors:  Jonathan E Feig; Jessica L Feig; George D Dangas
Journal:  Coron Artery Dis       Date:  2016-11       Impact factor: 1.439

3.  Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting.

Authors:  Young-Cheoul Doo; Sang-Jin Han; Sung-Woo Han; Woo-Jung Park; Seung-Hyuk Choi; Goo-Yeong Cho; Kyung-Soon Hong; Kyoo-Rok Han; Nam-Ho Lee; Dong-Jin Oh; Kyu-Hyung Ryu; Chong-Yun Rim; Kwang-Hahk Lee; Yung Lee
Journal:  Clin Cardiol       Date:  2005-02       Impact factor: 2.882

4.  Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice.

Authors:  John T Melchior; John D Olson; Kathryn L Kelley; Martha D Wilson; Janet K Sawyer; Kerry M Link; Lawrence L Rudel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-30       Impact factor: 8.311

5.  Nanoparticle-based "Two-pronged" approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux.

Authors:  Hongliang He; Jing Wang; Paul J Yannie; William J Korzun; Hu Yang; Shobha Ghosh
Journal:  Biomaterials       Date:  2020-08-15       Impact factor: 12.479

6.  The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.

Authors:  Shu-Fen Wung; Medha V Kulkarni; Clive R Pullinger; Mary J Malloy; John P Kane; Bradley E Aouizerat
Journal:  Lipids Health Dis       Date:  2006-07-05       Impact factor: 3.876

7.  Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits.

Authors:  Paula R Augusti; Andréia Quatrin; Sabrina Somacal; Greicy Mm Conterato; Rocheli Sobieski; Amanda R Ruviaro; Luana H Maurer; Marta Mf Duarte; Miguel Roehrs; Tatiana Emanuelli
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

8.  Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression.

Authors:  Karishma Rahman; Edward A Fisher
Journal:  Front Cardiovasc Med       Date:  2018-05-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.